Bolt Biotherapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-9.6M | $-10.0M | $373.0K | $225.0K |
| Jun 2020 | $-12.3M | $-13.1M | $840.0K | $223.0K |
| Sep 2020 | $-12.5M | $-13.7M | $1.2M | $403.0K |
| Dec 2020 | $-12.9M | $-13.8M | $898.0K | $569.0K |
| Mar 2021 | $-16.6M | $-16.6M | $58.0K | $2.1M |
| Jun 2021 | $-4.0M | $-4.7M | $703.0K | $2.0M |
| Sep 2021 | $-18.7M | $-19.7M | $1.0M | $2.2M |
| Dec 2021 | $-17.8M | $-18.4M | $562.0K | $2.1M |
| Mar 2022 | $-24.3M | $-24.9M | $605.0K | $2.9M |
| Jun 2022 | $-20.8M | $-21.2M | $429.0K | $2.4M |
| Sep 2022 | $-13.5M | $-14.2M | $735.0K | $2.1M |
| Dec 2022 | $-18.0M | $-18.1M | $184.0K | $2.1M |
| Mar 2023 | $-23.4M | $-23.4M | $3.0K | $2.5M |
| Jun 2023 | $-15.1M | $-15.1M | $32.0K | $2.4M |
| Sep 2023 | $-16.7M | $-16.9M | $165.0K | $2.3M |
| Dec 2023 | $-14.3M | $-14.3M | $6.0K | $2.1M |
| Mar 2024 | $-16.8M | $-16.8M | $0 | $2.3M |
| Jun 2024 | $-16.1M | $-16.1M | $0 | $2.8M |
| Sep 2024 | $-14.0M | $-14.0M | $41.0K | $1.1M |
| Dec 2024 | $-14.4M | $-14.4M | $0 | $1.2M |
| Mar 2025 | $-13.4M | $-13.4M | — | $709.0K |
| Jun 2025 | $-9.6M | $-9.6M | — | $625.0K |
| Sep 2025 | $-9.7M | $-9.7M | — | $407.0K |
| Dec 2025 | $-7.2M | $-7.2M | — | $1.0M |
| Mar 2026 | $-8.0M | $-8.0M | — | $545.0K |
| Jun 2026 | $-6.5M | $-6.5M | — | $552.0K |